These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1735524)

  • 21. Prognosis of corticosteroid-treated hepatitis B surface antigen-negative chronic active hepatitis in postmenopausal women: a retrospective analysis.
    Wang KK; Czaja AJ
    Gastroenterology; 1989 Nov; 97(5):1288-93. PubMed ID: 2792661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic predispositions for the immunological features of chronic active hepatitis.
    Czaja AJ; Carpenter HA; Santrach PJ; Moore SB
    Hepatology; 1993 Oct; 18(4):816-22. PubMed ID: 8406354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Autoimmune hepatitis].
    Marcais O; Larrey D
    Rev Prat; 1994 Jan; 44(1):75-9. PubMed ID: 8178063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus infection as a determinant of behavior in type 1 autoimmune hepatitis.
    Czaja AJ; Magrin S; Fabiano C; Fiorentino G; Diquattro O; Craxi A; Pagliaro L
    Dig Dis Sci; 1995 Jan; 40(1):33-40. PubMed ID: 7529673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute hepatitis A virus infection: a review of prognostic factors from 25 years experience in a tertiary referral center.
    Kyrlagkitsis I; Cramp ME; Smith H; Portmann B; O'Grady J
    Hepatogastroenterology; 2002; 49(44):524-8. PubMed ID: 11995487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is severe cryptogenic chronic hepatitis similar to autoimmune hepatitis?
    Kaymakoglu S; Cakaloglu Y; Demir K; Türkoglu S; Badur S; Gürel S; Beşişik F; Cevikbaş U; Okten A
    J Hepatol; 1998 Jan; 28(1):78-83. PubMed ID: 9537867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoimmune hepatitis in childhood: a 20-year experience.
    Gregorio GV; Portmann B; Reid F; Donaldson PT; Doherty DG; McCartney M; Mowat AP; Vergani D; Mieli-Vergani G
    Hepatology; 1997 Mar; 25(3):541-7. PubMed ID: 9049195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis.
    Perdigoto R; Carpenter HA; Czaja AJ
    J Hepatol; 1992 Mar; 14(2-3):325-31. PubMed ID: 1500696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Autoimmune hepatitis: two case reports with different clinical courses - case 3/2011].
    Minkley L; Adam P; Klein R; Lauer U
    Dtsch Med Wochenschr; 2011 Mar; 136(9):436. PubMed ID: 21374554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis.
    Czaja AJ; Hay JE; Rakela J
    Mayo Clin Proc; 1990 Jan; 65(1):23-30. PubMed ID: 2296210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and prognosis of histologic cirrhosis in corticosteroid-treated hepatitis B surface antigen-negative chronic active hepatitis.
    Davis GL; Czaja AJ; Ludwig J
    Gastroenterology; 1984 Dec; 87(6):1222-7. PubMed ID: 6489694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapy of autoimmune hepatitis].
    Rambusch EG; Manns MP
    Dtsch Med Wochenschr; 1996 Dec; 121(49):1539-42. PubMed ID: 8998922
    [No Abstract]   [Full Text] [Related]  

  • 33. Low-dose corticosteroid therapy after multiple relapses of severe HBsAg-negative chronic active hepatitis.
    Czaja AJ
    Hepatology; 1990 Jun; 11(6):1044-9. PubMed ID: 2365282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis.
    Czaja AJ; Rakela J; Ludwig J
    Gastroenterology; 1988 Aug; 95(2):448-53. PubMed ID: 3391372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis.
    Bach N; Thung SN; Schaffner F
    Hepatology; 1992 Apr; 15(4):572-7. PubMed ID: 1551632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis.
    Soloway RD; Summerskill WH; Baggenstoss AH; Geall MG; Gitnićk GL; Elveback IR; Schoenfield LJ
    Gastroenterology; 1972 Nov; 63(5):820-33. PubMed ID: 4538724
    [No Abstract]   [Full Text] [Related]  

  • 37. Autoimmunity in liver diseases.
    Doniach D
    Prog Clin Immunol; 1972; 1():45-70. PubMed ID: 4142094
    [No Abstract]   [Full Text] [Related]  

  • 38. Chronic active liver disease reexamined: prognosis hopeful.
    Summerskill WH
    Gastroenterology; 1974 Mar; 66(3):450-64. PubMed ID: 4591728
    [No Abstract]   [Full Text] [Related]  

  • 39. Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated cryptogenic chronic active hepatitis.
    Czaja AJ; Taswell HF; Rakela J; Schimek CM
    Mayo Clin Proc; 1990 Oct; 65(10):1303-13. PubMed ID: 2170781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated autoimmune chronic active hepatitis.
    Czaja AJ; Taswell HF; Rakela J; Schimek CM
    Mayo Clin Proc; 1991 Jun; 66(6):572-82. PubMed ID: 1646353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.